Placental gene transfer: transgene screening in mice for trophic effects on the placenta

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 5, 2009, Pages 499.e1-499.e8

  Katz, Anna B ^a   Keswani, Sundeep G ^a   Habli, Mounira ^a   Lim, Foong Y ^a   Zoltick, Philip W ^b   Midrio, Paola ^b   Kozin, Elliot D ^a   Herlyn, Meenhard ^c   Crombleholme, Timothy M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c WISTAR INSTITUTE   (United States)

Author keywords

gene therapy; growth factors; intrauterine growth restriction; placenta

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; BASIC FIBROBLAST GROWTH FACTOR; BETA GALACTOSIDASE; PHOSPHATE BUFFERED SALINE; PLACENTAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR B; SCATTER FACTOR; SOMATOMEDIN C; VASCULOTROPIN 121;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FETUS; FETUS GROWTH; FETUS WEIGHT; GENE OVEREXPRESSION; GENE TRANSFER; HISTOLOGY; INTRAUTERINE GROWTH RETARDATION; MOUSE; NONHUMAN; PLACENTA; PLACENTA DEVELOPMENT; PLACENTA INSUFFICIENCY; PLACENTA WEIGHT; PLACENTAL GENE TRANSFER; PRIORITY JOURNAL; SURVIVAL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; FEMALE; GENE TRANSFER TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED BALB C; PLACENTA; PREGNANCY;

EID: 70350573626     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.06.029     Document Type: Article

References (44)

1. Peregrine E., and Peebles D. Fetal growth and growth restriction. In: Rodeck C.H., and Whittle M.J. (Eds). Fetal medicine: basic science and clinical practice (2009), Churchill Livingstone Elsevier, London, UK 541-558
2. McCormick M.C. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 312 (1985) 82
3. Barker D.J. Fetal origins of coronary heart disease. Br Med J 311 (1995) 171-174
4. Barker D.J., Hales C.N., Fall C.H., et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36 (1993) 62-67
5. Baschat A.A. Fetal responses to placental insufficiency: an update. BJOG 111 (2004) 1031-1041
6. Smith N., and Lasic D. Gene therapy: therapeutic mechanisms and strategies (2000), Marcel Dekker, New York
7. Geva E., Ginzinger D.G., Zaloudek C.J., et al. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 87 (2002) 4213-4224
8. Charnock-Jones D.S. Soluble flt-1 and the angiopoietins in the development and regulation of placental vasculature. J Anat 200 (2002) 607-615
9. Dunk C., Shams M., Nijjar S., et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast tie-2 to promote growth and migration during placental development. Am J Pathol 156 (2000) 2185-2199
10. Wei P., Yu F.Q., Chen X.L., et al. VEGF, bFGF and their receptors at the fetal-maternal interface of the rhesus monkey. Placenta 25 (2004) 184-196
11. Burleigh D.W., Stewart K., Grindle K.M., et al. Influence of maternal diabetes on placental fibroblast growth factor-2 expression, proliferation, and apoptosis. J Soc Gynecol Investig 11 (2004) 36-41
12. Kauma S., Hayes N., and Weatherford S. The differential expression of hepatocyte growth factor and met in human placenta. J Clin Endocrinol Metab 82 (1997) 949-954
13. Patel Y., Kim H., and Rappolee D.A. A role for hepatocyte growth factor during early postimplantation growth of the placental lineage in mice. Biol Reprod 62 (2000) 904-912
14. Thakur A., Sase M., Lee J.J., et al. Ontogeny of insulin-like growth factor I in a rabbit model of growth retardation. J Surg Res 91 (2000) 135-140
15. Lok F., Owens J.A., Mundy L., et al. Insulin-like growth factor I promotes growth selectively in fetal sheep in late gestation. Am J Physiol 270 (1996) R1148-R1155
16. Holmes R., Porter H., Newcomb P., et al. An immunohistochemical study of type I insulin-like growth factor receptors in the placentae of pregnancies with appropriately grown or growth restricted fetuses. Placenta 20 (1999) 325-330
17. Giudice L.C., de Zehger F., Gargosky S.E., et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 80 (1995) 1548-1555
18. Alsat E., Guibourdenche J., Couturier A., and Evain-Brion D. Physiological role of human placental growth hormone. Mol Cell Endocrinol 140 (1998) 121-127
19. Taylor R., and Williams L. Developmental expression of platelet-derived growth factor and its receptor in the human placenta. Mol Endocrinol 2 (1998) 627-632
20. Ohlsson R., Falck P., Hellstrom M., et al. PDGFB regulates the development of the labyrinthine layer of the mouse fetal placenta. Dev Biol 212 (1999) 124-136
21. Vonnahme K.A., and Ford S.P. Placental vascular endothelial growth factor receptor system mRNA expression in pigs selected for placental efficiency. J Physiol 554 (2004) 194-201
22. Gruss C.J., Satyamoorthy K., Berking C., et al. Stroma formation and angiogenesis by overexpression of growth factors, cytokines, and proteolytic enzymes in human skin grafted to SCID mice. J Invest Dermatol 120 (2003) 683-692
23. Davis A.R., and Wilson J.M. Adenoviral vectors. In: Dracopoli N.C., Haines J.L., and Korf B.R. (Eds). Current protocols in human genetics (1994), John Wiley & Sons, New York 12.4.1
24. Ng P., and Graham F.L. Construction of first-generation adenoviral vectors. Methods Mol Med 69 (2002) 389-414
25. Yang E.Y., Kim H.B., Shaaban A.F., et al. Persistent postnatal transgene expression in both muscle and liver after fetal injection of recombinant adenovirus. J Pediatr Surg 34 (1999) 766-772
26. Mayhew T.M. The new stereological methods for interpreting functional morphology from slices of cells and organs. Exp Physiol 76 (1991) 639-665
27. Suri C., Jones P.F., Patan S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
28. Wulff C., Wilson H., Dickson S.E., et al. Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy. Biol Reprod 66 (2002) 802-812
29. Tsatsaris V., Goffin F., Munaut C., et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 88 (2003) 5555-5563
30. Levine R.J., Maynard S.E., Qian C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
31. Hattori K., Dias S., Heissig B., et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 193 (2001) 1005-1014
32. Griesenbach U., Munkonge F.M., Sumner-Jones S., et al. Assessment of CFTR function after gene transfer in vitro and in vivo. Methods Mol Biol 433 (2008) 229-242
33. Rossant J., and Cross J.C. Placental development: lessons from mouse mutants. Nat Rev Genet 2 (2001) 538-548
34. Mulligan R.C. The basic science of gene therapy. Science 260 (1993) 926-932
35. Penta M., Lukic A., Conte M.P., et al. Infectious agents in tissues from spontaneous abortions in the first trimester of pregnancy. New Microbiol 26 (2003) 329-337
36. Wenstrom K.D., Andrews W.W., Bowles N.E., et al. Intrauterine viral infection at the time of second trimester genetic amniocentesis. Obstet Gynecol 92 (1998) 420-424
37. Buchschacher Jr. G.L., and Wong-Staal F. Development of lentiviral based vectors for human based gene therapy. Blood 95 (2000) 2499-2504
38. Lu Y. Recombinant adeno-associated virus as delivery vector for gene therapy-a review. Stem Cells Dev 13 (2004) 133-145
39. Thurston G. Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. J Anat 200 (2002) 575-580
40. Nesbit M., Nesbit H.K., Bennett J., et al. Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene 18 (1999) 6469-6476
41. Phaneuf D., Chen S.J., and Wilson J.M. Intravenous injection of an adenovirus encoding hepatocyte growth factor results in liver growth and has a protective effect against apoptosis. Mol Med 6 (2000) 96-103
42. Satyamoorthy K., Li G., Vaidya B., et al. IGF-1 induces survival and growth in biologically early melanoma cells through both the MAP kinase and β-catenin pathways. Cancer Res 61 (2001) 7318-7324
43. Liechty K.W., Nesbit M., Herlyn M., et al. Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing. J Invest Dermatol 113 (1999) 375-383
44. Samadi D.S., Jacobs I.N., Walsh D., et al. Adenovirus-mediated ex vivo gene transfer of human vascular endothelial growth factor in a rabbit laryngotracheal reconstruction model. Ann Otol Rhinol Laryngol 111 (2002) 295-301